Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients. Reumatismo [Internet]. 2023 Jul. 17 [cited 2025 Jul. 10];75(2). Available from: https://www.reumatismo.org/reuma/article/view/1544